Loading clinical trials...
Loading clinical trials...
A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Fluticasone Propionate/Albuterol Sulfate Combination Compared to Fluticasone Propionate, Albuterol Sulfate or Placebo Delivered by Multidose Dry Powder Inhaler in Participants 12 Years and Older With Asthma
Conditions
Interventions
Fp/ABS
FP
+2 more
Locations
149
United States
Teva Investigational Site 12087
Phoenix, Arizona, United States
Teva Investigational Site 12144
Phoenix, Arizona, United States
Teva Investigational Site 12104
Tucson, Arizona, United States
Teva Investigational Site 12146
Tucson, Arizona, United States
Teva Investigational Site 12102
Little Rock, Arkansas, United States
Teva Investigational Site 12154
Encinitas, California, United States
Start Date
December 12, 2024
Primary Completion Date
May 31, 2026
Completion Date
May 31, 2026
Last Updated
April 21, 2026
NCT06979323
NCT07431021
NCT07383896
NCT07282886
NCT07356310
NCT06003569
Lead Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions